Anti-viral compounds

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 8546405
APP PUB NO 20100160355A1
SERIAL NO

12644432

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

Compounds effective in inhibiting replication of Hepatitis C virus (“HCV”) are described. This invention also relates to processes of making such compounds, compositions comprising such compounds, and methods of using such compounds to treat HCV infection.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

  • ABBVIE INC.

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
DeGoey, David A Salem, US 53 774
Donner, Pamela L Mundelein, US 35 838
Hutchins, Charles W Green Oaks, US 94 1934
Kati, Warren M Gurnee, US 54 786
Krishnan, Preethi Gurnee, US 12 94
Krueger, Allan C Gurnee, US 52 689
Li, Xiaoyan Waukegan, US 51 166
Mistry, Neeta C Mundelein, US 5 93
Motter, Christopher E Oak Creek, US 23 470
Nelson, Lissa T Highland Park, US 14 279
Patel, Sachin V Round Lake, US 31 364
Pilot-Matias, Tami J Green Oaks, US 27 375
Randolph, John T Libertyville, US 66 586
Soltwedel, Todd N Chicago, US 7 256

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
11.5 Year Payment $7400.00 $3700.00 $1850.00 Apr 1, 2025
Fee Large entity fee small entity fee micro entity fee
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00